Why Global Oncology Evidence May Not Support U.S. Regulatory Approval
|
FDA Veteran Paz Vellanki, MD, joins Precision to become one of 3 ex-FDA oncology leaders supporting clients
In the rapidly evolving regulatory environment, having a reliable partner is essential. Precision is proud to have facilitated numerous complex submissions, achieving significant regulatory milestones:
Every module within eCTD submissions requires unique expertise. Guided by robust program management principles, our multidisciplinary teams across regulatory affairs, biostatistics, statistical programming and medical writing collaborate seamlessly through the submission journey.
At Precision, our regulatory specialists manage publication processes with utmost care and adeptness. To enhance reviewer convenience, we adopt a comprehensive approach to data publishing, incorporating intuitive metadata tagging, hyperlinks, and bookmarks. Following meticulous final assembly, rigorous validation, and multiple layers of scrutiny, we guarantee that only high-quality submissions successfully traverse the designated electronic gateway.
As the regulatory review progresses, we assist you with responding to additional information requests and queries, leading up to the point of approval.
Stay updated with the latest insights in eCTD publishing and submission through our blog.
Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to accelerate speed to market. Precision can customize and converge our capabilities to meet your program's unique needs—driving efficiency, agility, and success from start to finish.
Award-winning CRO with deep oncology and rare disease expertise
Discover Explore
Exceptional translational and biomarker sciences with global central lab services
Contact us to learn more about how Precision for Medicine can partner with you to drive optimization in regulatory submissions.